[PDF][PDF] Vasoactive intestinal peptide receptor scintigraphy
I Virgolini, A Kurtaran, M Raderer… - Journal of Nuclear …, 1995 - Soc Nuclear Med
Results After injection of labeled peptide, the lung was the primary site of 123l-VIPuptake.
Peak lung activity represented 40% ±7% of the injected dose at 0.7 hr and declined to 21 …
Peak lung activity represented 40% ±7% of the injected dose at 0.7 hr and declined to 21 …
99mTc-labeled vasoactive intestinal peptide receptor agonist: functional studies
VR Pallela, ML Thakur, S Chakder… - The Journal of Nuclear …, 1999 - search.proquest.com
Vasoactive intestinal peptide (VIP) is a naturally occurring 28-amino acid peptide with a
wide range of biological activities. Recent reports suggest that VIP receptors are expressed …
wide range of biological activities. Recent reports suggest that VIP receptors are expressed …
In vivo dynamical distribution of 131I-VIP in the rat studied by gamma-camera
The in vivo distribution of vasoactive intestinal peptide (VIP) was studied for the first time
using a rat model in combination with labeled VIP (131 I-VIP) and a gamma-camera. A …
using a rat model in combination with labeled VIP (131 I-VIP) and a gamma-camera. A …
Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours
C Hessenius, M Bäder, H Meinhold, M Böhmig… - European journal of …, 2000 - Springer
Human adenocarcinomas of the gastroenteropancreatic system overexpress vasoactive
intestinal peptide (VIP) receptors and therefore represent logical diagnostic targets for …
intestinal peptide (VIP) receptors and therefore represent logical diagnostic targets for …
Imaging tumors in humans with Tc‐99m‐VIP
ML Thakur, CS Marcus, S Saeed… - Annals of the New …, 2000 - Wiley Online Library
Vasoactive intestinal peptide (VIP) was modified at the C terminus with a spacer and four
amino acids to serve as a chelating moiety. The modified peptide, TP 3654, was labeled with …
amino acids to serve as a chelating moiety. The modified peptide, TP 3654, was labeled with …
[PDF][PDF] Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy
M Raderer, A Becherer, A Kurtaran… - Journal of Nuclear …, 1996 - Soc Nuclear Med
METHODS Patients and Study Design Forty patients with histologically verified
adenocarcinoma of the colon, pancreas and stomach were randomized between scanning …
adenocarcinoma of the colon, pancreas and stomach were randomized between scanning …
[PDF][PDF] Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.
JR Carstairs, PJ Barnes - Journal of Pharmacology and Experimental …, 1986 - Citeseer
Binding of [1251] vasoactive intestinal peptide (VIP) to human and guinea pig lung sections
was characterized and VIP receptors localized by light-microscopic autoradiography …
was characterized and VIP receptors localized by light-microscopic autoradiography …
Characterization and localization of vasoactive intestinal peptide receptors in the rat lung
P Leroux, H Vaudry, A Fournier, S St-Pierre… - …, 1984 - academic.oup.com
Experiments were performed to characterize vasoactive intestinal peptide (VIP) receptors in
rat lung and to study their localization by means of light and electron microscope …
rat lung and to study their localization by means of light and electron microscope …
123I-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal …
I Virgolini, M Raderer, A Kurtaran, P Angelberger… - Nuclear medicine and …, 1996 - Elsevier
Recent data suggest that functional receptors (R) for vasoactive intestinal peptide (VIP) are
expressed on various tumor cells. The high-level expression of VIPR on tumor cells provided …
expressed on various tumor cells. The high-level expression of VIPR on tumor cells provided …
[PDF][PDF] In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging
JC Reubi - Journal of Nuclear Medicine, 1995 - Soc Nuclear Med
In vitro receptor measurements in tumors were performed to evaluate the potential ofthe
vasoactive intestinal peplide recap tor (VIP-A) as an imagingtoolinhuman cancer. Methods …
vasoactive intestinal peplide recap tor (VIP-A) as an imagingtoolinhuman cancer. Methods …